Garman lab: Interconversion of lysosomal enzyme specificities: Difference between revisions

Karsten Theis (talk | contribs)
Karsten Theis (talk | contribs)
No edit summary
 
(12 intermediate revisions by the same user not shown)
Line 1: Line 1:
==How this page was created==
==How this page was created==
The goal of this page is to provide three-dimensional and interactive figures to explore the structures determined for the 2010 paper "Interconversion of the Specificities of Human Lysosomal Enzymes Associated with Fabry and Schindler Diseases" by Ivan B. Tomasic, Matthew C. Metcalf, Abigail I. Guce, Nathaniel E. Clark and Scott C. Garman<ref name=primary>DOI: 10.1074/jbc.M110.118588</ref>. The starting point are the figures found in this paper. Biochemistry students at Westfield State University recreated these figures in jmol, and revised them after getting feedback from the authors. A special thank you goes to Susan Al Mahrwuth, Samuel J. Butler, Susy Civil, Westin G. Cohen, Allison F. DeVivo, Tyler S. Fassett, Courtney M. Fisher, Kimberly Garcia, Stephanie L. Hardy, Maureen W. Kamau, Sienna R. Kardel, Allyson L. Kress, Julia M. Lahaie, Stephen A. Malerba, Brittany E. Ricci, Kimberly Rosario, Yelena Vynar, and Deanna N. Womack for creating the initial figures and captions. If you are interested to learn how these figures were made, take a look at the discussion page (2nd tab above).
The goal of this page is to provide three-dimensional and interactive figures to explore the structures determined for the 2010 paper "Interconversion of the Specificities of Human Lysosomal Enzymes Associated with Fabry and Schindler Diseases" by Ivan B. Tomasic, Matthew C. Metcalf, Abigail I. Guce, Nathaniel E. Clark and Scott C. Garman<ref name=primary>DOI: 10.1074/jbc.M110.118588</ref>. The starting point are the figures found in this paper. Biochemistry students at Westfield State University recreated these figures in jmol, and revised them after getting feedback from the authors. A special thank you goes to Susan Al Mahrwuth, Samuel J. Butler, Susy Civil, Westin G. Cohen, Allison F. DeVivo, Tyler S. Fassett, Courtney M. Fisher, Kimberly Garcia, Stephanie L. Hardy, Maureen W. Kamau, Sienna R. Kardel, Allyson L. Kress, Julia M. Lahaie, Stephen A. Malerba, Brittany E. Ricci, Kimberly Rosario, Yelena Vynar, and Deanna N. Womack for creating the initial figures and captions. If you are interested to learn how these figures were made, take a look at the discussion page ([http://proteopedia.org/wiki/index.php/Talk:Garman_lab:_Interconversion_of_lysosomal_enzyme_specificities 2nd tab above]).


== Lysosomal storage disease ==
== Lysosomal storage disease ==
Line 33: Line 33:
== Overview of the research, and recreated figures==
== Overview of the research, and recreated figures==
<StructureSection load='' size='540' side='right' caption='Colors used for proteins throughout: green (GAL), blue(NAGAL), yellow (GAL(SA))' scene='78/786673/Galnac/2'>
<StructureSection load='' size='540' side='right' caption='Colors used for proteins throughout: green (GAL), blue(NAGAL), yellow (GAL(SA))' scene='78/786673/Galnac/2'>
The research is about two related enzymes, GAL and NAGAL. They are found in the same location in the human body (in the lysosome, an acidic organelle responsible for breaking down molecules the cell no longer needs), their primary sequence is 50% identical, they catalyze the same reaction (hydrolysis of α-glycosidic bonds), and they have very similar active sites. However, they differ in substrate specificity (one cleaves the bond with galactose, and the other with N-acetyl glalactosamine). In terms of structure, the backbone conformation is quite similar (Fig. 1 panel B and C: compare <scene name='78/786673/Gal_overall/5'>GAL</scene> and <jmol>
The research is about two related enzymes, GAL and NAGAL. They are found in the same location in the human body (in the lysosome, an acidic organelle responsible for breaking down molecules the cell no longer needs), their primary sequence is 50% identical, they catalyze the same reaction (hydrolysis of α-glycosidic bonds), and they have very similar active sites. However, they differ in substrate specificity (one cleaves the bond with galactose, and the other with N-acetyl glalactosamine). In terms of structure, the backbone conformation is quite similar (Fig. 1 panel B and C: compare <scene name='78/786673/Gal_overal_view/1'>GAL</scene> and <jmol><jmolLink><script>script "/scripts/78/786673/Gal_overal_view/1.spt"; ppdiaCaptionCmd = "changeCaption('The enyme NAGAL (blue) in complex with the sugar N-acetyl galactosamin (thick wireframe), with glycolysation shown as thin wireframe. View along the 2-fold axis of the dimer. ','white','black');";javascript @ppdiaCaptionCmd;model 2;</script><text>NAGAL</text></jmolLink></jmol>.  
<jmolLink>
  <script> model 2
  </script>
  <text>NAGAL</text>
</jmolLink>
</jmol>). The active sites differ in only two residues, and the substrates bind in almost the same way (Fig 1 panel B and C insets: compare the active site of <scene name='78/786673/Gal_active_site/5'>GAL</scene> and <jmol>
<jmolLink>
  <script> model 2
  </script>
  <text>NAGAL</text>
</jmolLink>
</jmol>).  


The researchers asked the following question: Is it possible to turn one enzyme into the other (in terms of reaction catalyzed)? Their hypothesis was that a simple swap of the two amino acids in the active site that are different would accomplish an interconversion of specificities.
The researchers asked the following question: Is it possible to turn one enzyme into the other (in terms of reaction catalyzed)? Their hypothesis was that a simple swap of the two amino acids in the active site that are different would accomplish an interconversion of specificities.


To test this, they made variants called GAL(SA) and NAGAL(EL), in which one active site has the amino acids of the other active site and vice versa (by swapping the two residues that are different). The data obtained by enzyme kinetics supported their hypothesis; the preference for galactose vs N-acetyl galactosamine is swapped (not shown here, but the data is in their paper<ref name=primary/>). Crystal structures (Fig. 2 panel A and B) show how GAL(SA) is able to bind to either <scene name='78/786673/Fig2a_galnac_complex/2'>N-acetyl galactosamine</scene> or <scene name='78/786673/Galsa_gal/21'>galactose</scene>. Comparing the structures of the NAGAL: N-acetyl galactosamine complex and the GAL(SA): N-acetyl galactosamine complex (Fig. 2 panel D) shows that <scene name='78/786673/Galsa_nagal/2'>they bind the ligand in a very similar manner</scene>.
To test this, they made variants called GAL(SA) and NAGAL(EL), in which one active site has the amino acids of the other active site and vice versa (by swapping the two residues that are different). The data obtained by enzyme kinetics supported their hypothesis; the preference for galactose vs N-acetyl galactosamine is swapped (not shown here, but the data is in their paper<ref name=primary/>). Crystal structures (Fig. 2 panel A and B) show how GAL(SA) is able to bind to either <scene name='78/786673/Fig2a_galnac_complex/2'>N-acetyl galactosamine</scene> or <scene name='78/786673/Galsa_gal/21'>galactose</scene>. Comparing the structures of the NAGAL: N-acetyl galactosamine complex and the GAL(SA): N-acetyl galactosamine complex (Fig. 2 panel D) shows that <scene name='78/786673/Nagal_galsa_superposition/1'>they bind the ligand in a very similar manner</scene>.


You can explore the structural data further by going through the figures below and clicking on the buttons. If during your exploration you get lost or some figures behave strangely, press <scene name='78/786673/Galnac/2'>here</scene> first to reset the 3D browser and then try again.
You can explore the structural data further by going through the figures below and clicking on the buttons. If during your exploration you get lost or some figures behave strangely, press <scene name='78/786673/Galnac/2'>here</scene> first to reset the 3D browser and then try again.
Line 63: Line 51:
<jmol>
<jmol>
<jmolButton>
<jmolButton>
<script>!exit; ppdiaCaptionCmd = "changeCaption('The enyme GAL (green) in complex with the sugar galactose (thick wireframe), with glycolysation shown as thin wireframe. View along the 2-fold axis of the dimer. ','white','black');"; javascript @ppdiaCaptionCmd; delay 1.2; model 1</script>
<script>!exit; ppdiaCaptionCmd = "changeCaption('The enyme GAL (green) in complex with the sugar galactose. ','white','black');"; javascript @ppdiaCaptionCmd; model 1</script>
   <text>GAL</text>
   <text>GAL</text>
</jmolButton>
</jmolButton>
</jmol><jmol>
</jmol> <jmol>
<jmolButton>
<jmolButton>
<script>!exit; ppdiaCaptionCmd = "changeCaption('The enyme NAGAL (blue) in complex with the sugar N-acetyl galactosamin (thick wireframe), with glycolysation shown as thin wireframe. View along the 2-fold axis of the dimer. ','white','black');";
<script>!exit; ppdiaCaptionCmd = "changeCaption('The enyme NAGAL (blue) in complex with the sugar N-acetyl galactosamin. ','white','black');";
   javascript @ppdiaCaptionCmd;delay 1.5; model 2</script>
   javascript @ppdiaCaptionCmd;model 2</script>
   <text>NAGAL</text>
   <text>NAGAL</text>
</jmolButton>
</jmolButton>
</jmol>
</jmol> <jmol>
<jmol>
<jmolButton>
<jmolButton>
<script>!exit; ppdiaCaptionCmd = "changeCaption('Superposition of GAL (green) and NAGAL (blue). View along the 2-fold axis of the dimer. ','white','black');"; javascript @ppdiaCaptionCmd; delay 1.5; model 0</script>
<script>!exit; ppdiaCaptionCmd = "changeCaption('Superposition of GAL (green) and NAGAL (blue).','white','black');"; javascript @ppdiaCaptionCmd; model 0</script>
   <text>both</text>
   <text>both</text>
</jmolButton>
</jmolButton>
</jmol>
</jmol> <jmol>
<jmol>
<jmolButton>
<jmolButton>
<script>animation mode loop; ppdiaCaptionCmd = "changeCaption('Superposition of GAL (green) and NAGAL (blue). View along the 2-fold axis of the dimer. ','white','black');"; javascript @ppdiaCaptionCmd; animation on</script>
<script>animation mode loop; ppdiaCaptionCmd = "changeCaption('Animated superposition of GAL (green) and NAGAL (blue).','white','black');"; javascript @ppdiaCaptionCmd; animation on</script>
   <text>animate</text>
   <text>animate</text>
</jmolButton>
</jmolButton>
Line 91: Line 77:
For the animation in Figure 1, the carbon alpha atoms of the shown active site residues were superimposed (RMSD = 0.3 Å). The following views of the active site differences shows a superposition of the six common carbon atoms (RMSD = 0.02 Å) in the bound sugar. It becomes obvious that the sugar is bound in a slightly different orientation with respect to the overall protein structure.
For the animation in Figure 1, the carbon alpha atoms of the shown active site residues were superimposed (RMSD = 0.3 Å). The following views of the active site differences shows a superposition of the six common carbon atoms (RMSD = 0.02 Å) in the bound sugar. It becomes obvious that the sugar is bound in a slightly different orientation with respect to the overall protein structure.


<scene name='78/786673/Bonus/1'>α-GAL active site</scene>
<scene name='78/786673/Gal_nagal_other_superposition/1'>α-GAL active site</scene>


(use the buttons above to compare with NAGAL)
(use the buttons above to compare with NAGAL)
Line 109: Line 95:
GAL(SA) is derived from GAL by replacing actives site residues glutamate 203 with serine and leucine 206 with alanine. Having these smaller amino acids in the active site increases the substrate binding cavity, and makes the active site of αGAL(SA) very similar to that of αNAGAL. With these substitutions, the catalytic activity of GAL(SA) is more similar to NAGAL than to GAL (the data is not shown here, but can be found in the research paper<ref name=primary/>).  
GAL(SA) is derived from GAL by replacing actives site residues glutamate 203 with serine and leucine 206 with alanine. Having these smaller amino acids in the active site increases the substrate binding cavity, and makes the active site of αGAL(SA) very similar to that of αNAGAL. With these substitutions, the catalytic activity of GAL(SA) is more similar to NAGAL than to GAL (the data is not shown here, but can be found in the research paper<ref name=primary/>).  


<scene name='78/786673/Fig2a_galnac_complex/2'>Panel A</scene>: in complex with N-acetyl galactosamine
<jmol><jmolLink><script>script "/scripts/78/786673/Fig2a_galnac_complex/3.spt"; ppdiaCaptionCmd = "changeCaption('Crystal structure of GAL(SA) bound to N-acetyl galactosamine. GAL(SA) active site residues are shown in yellow and the product, N-acetyl galactosamine, is shown in gray. The blue mesh around the sugar represents its (2Fo-Fc) electron density.','white','black');";javascript @ppdiaCaptionCmd;model 2; model 2</script><text>Panel A</text></jmolLink></jmol>: in complex with N-acetyl galactosamine


Crystal structure of GAL(SA) bound to N-acetyl galactosamine. GAL(SA) active site residues are shown in yellow and the product, N-acetyl galactosamine, is shown in gray. The blue mesh around the sugar represents its (2Fo-Fc) electron density.


Use the buttons to hide the model of the sugar in the figure. This is what a crystallographer would interpret to figure out what is bound in the active site.
Use the buttons to hide the model of the sugar in the figure. This is what a crystallographer would interpret to figure out what is bound in the active site.
Line 129: Line 114:
</jmol>
</jmol>


<scene name='78/786673/Galsa_gal/21'>Panel B</scene>: in complex with galactose
<jmol><jmolLink><script>script "/scripts/78/786673/Galsa_gal/2.spt"; ppdiaCaptionCmd = "changeCaption('Crystal structure of GAL(SA) bound to galactose. GAL(SA) active site residues are shown in yellow and the product, galactose, is shown in gray. The blue mesh around the sugar represents its (2Fo-Fc) electron density.','white','black');";javascript @ppdiaCaptionCmd;model 2; model 2</script><text>Panel B</text></jmolLink></jmol>: in complex with galactose


<jmol>
<jmol>
Line 145: Line 130:
</jmol>
</jmol>


<scene name='78/786673/Galsa_nagal/2'>Panel D</scene>: Superposition with alpha-NAGAL bound to GalNAc


Superposition of structures: GAL(SA) bound to N-acetyl glucosamine, in yellow, and NAGAL bound to N-acetyl glucosamine, in dark blue. The sugar bound to GAL(SA) is shown in light brown and the one bound to NAGAL is shown in light blue.
<scene name='78/786673/Nagal_galsa_superposition/1'>Panel D</scene>: Superposition with alpha-NAGAL bound to GalNAc
 
<jmol>
<jmol>
<jmolButton>
  <jmolCheckbox>
<script>animation mode loop; animation on</script>
    <scriptWhenUnChecked>animation off; model 0
  <text>animate</text>
      </scriptWhenUnChecked>
</jmolButton>
    <scriptWhenchecked>animation mode loop; animation on
      </scriptWhenchecked>
    <checked>false</checked>  
    <text>animation</text>
  </jmolCheckbox>
</jmol>
</jmol>


Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Karsten Theis